There are significant differences in CD163 protein expression in the margin or tumor tissue between 108 breast cancer specimens and 12 controls (Supplementary Figure 1A, p = 0.0015, p = 0.0002, respectively). This evidence concerns the gene CD163 and breast carcinoma.